Hospital General Universitario Santa Lucía
Cartagena, Murcia, Spain
General hospital in Spain
C. Minarete, s/n, 30202 Cartagena, Murcia
About Hospital General Universitario Santa Lucía
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital General Universitario Santa Lucía
During the past decade, Hospital General Universitario Santa Lucía conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 3 clinical trials were completed, i.e. on
average, 9.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis
2008-07-17
2023-12-16
Active, not recruiting
220
A Study of Ocrelizumab in Participants With Primary Progressive Multiple Sclerosis
2011-03-02
2022-12-31
Completed
735
A Study of Atezolizumab in Combination With Carboplatin or Cisplatin + Pemetrexed Compared With Carboplatin or Cisplatin + Pemetrexed in Participants Who Are Chemotherapy-Naive and Have Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower 132)
2016-04-30
2022-12-13
Completed
578
A Study Evaluating the Efficacy and Safety of Crenezumab Versus Placebo in Participants With Prodromal to Mild Alzheimer's Disease (AD).
2016-03-22
2019-05-31
Terminated
813
A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2018-08-10
2024-03-31
Active, not recruiting
135
Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis
2018-11-12
2025-07-26
Active, not recruiting
1,700
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)
2020-11-26
2029-03-30
Recruiting
865
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
2020-10-26
2026-12-18
Recruiting
946
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital General Universitario Santa Lucía" #1 sponsor was "PETHEMA Foundation" with 5 trials, followed by "Celgene" with 4 trials
sponsored, "Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia" with 2 trials sponsored, "Grupo de Investigación Clínica en Oncología Radioterapia" with 2 trials sponsored and "Takeda"
with 2 trials sponsored. Other sponsors include 22 different institutions and
companies that sponsored additional 32 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital General Universitario Santa Lucía"
#1 collaborator was "Dynamic Science S.L." with 2 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator, "Adknoma" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were
collaborators in the rest 27 trials.
Clinical Trials Conditions at Hospital General Universitario Santa Lucía
According to Clinical.Site data, the most researched conditions in "Hospital General Universitario Santa Lucía" are
"Multiple Myeloma" (4 trials), "Breast Cancer" (3 trials), "Leukemia, Myeloid, Acute" (2 trials), "Newly Diagnosed Multiple Myeloma" (2 trials) and "Acute Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Hospital General Universitario Santa Lucía" in a lesser frequency.
Clinical Trials Intervention Types at Hospital General Universitario Santa Lucía
Most popular intervention types in "Hospital General Universitario Santa Lucía" are "Drug" (17 trials), "Other" (6 trials), "Radiation" (4 trials), "Device" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Dexamethasone" (3 trials), "Bortezomib" (2 trials), "Irradiation" (2 trials), "Lenalidomide" (2 trials) and "Radiotherapy" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital General Universitario Santa Lucía
The vast majority of trials in "Hospital General Universitario Santa Lucía" are
33 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Hospital General Universitario Santa Lucía
Currently, there are NaN active trials in "Hospital General Universitario Santa Lucía".
1 are not yet recruiting,
8 are recruiting,
8 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 18 completed trials in Hospital General Universitario Santa Lucía,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital General Universitario Santa Lucía, 0 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 7 trials that are defined as “Not Applicable".